Exclusive

Publication

Byline

Location

US Patent Issued to PrimeGene (Beijing) on July 21 for "Process for the preparation of 2-{3-[3-amino-4-(7H-pyrrolo[2,3-dpyrimidin-4-yl)-1H-pyrazol-1-yl-1-(isopropylsulfonyl)azetidin-3-yl}acetonitrile" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,681, issued on July 21, was assigned to PrimeGene (Beijing) Co. Ltd. (Beijing). "Process for the preparation of 2-{3-[3-amino-4-(7H-pyrrolo... Read More


US Patent Issued to Hoffmann-La Roche on July 21 for "Indazole acetylene derivatives" (Swiss, British, French Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,682, issued on July 21, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Indazole acetylene derivatives" was invented by Cosim... Read More


US Patent Issued to DANATLAS PHARMACEUTICALS on July 21 for "Tricyclic heterocyclic derivatives, compositions and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,683, issued on July 21, was assigned to DANATLAS PHARMACEUTICALS Co. LTD. (Beijing). "Tricyclic heterocyclic derivatives, compositions and ... Read More


US Patent Issued to Ascentage Pharma (Suzhou), Ascentage Pharma Group on July 21 for "BTK degrader and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,684, issued on July 21, was assigned to Ascentage Pharma (Suzhou) Co. Ltd. (Suzhou, China) and Ascentage Pharma Group Corp Ltd. (Hong Kong).... Read More


US Patent Issued to Shanghai Shengping Medical Equipment, VastPro (Zhejiang) Pharmaceutical, Zhejiang Boxiao Biopharmaceutical on July 21 for "Method for large-scale synthesis of tetrodotoxin" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,685, issued on July 21, was assigned to Shanghai Shengping Medical Equipment Co. Ltd. (Shanghai), VastPro (Zhejiang) Pharmaceutical Co. Ltd.... Read More


US Patent Issued to SUN YAT-SEN UNIVERSITY on July 21 for "Daphnane diterpenoid resistant to prostate cancer and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,686, issued on July 21, was assigned to SUN YAT-SEN UNIVERSITY (Guangzhou, China). "Daphnane diterpenoid resistant to prostate cancer and p... Read More


US Patent Issued to FOGHORN THERAPEUTICS on July 21 for "Compounds and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,687, issued on July 21, was assigned to FOGHORN THERAPEUTICS INC. (Watertown, Mass.). "Compounds and uses thereof" was invented by Sabine K... Read More


US Patent Issued to SCHRODINGER on July 21 for "Heterocyclic pericondensed CDC7 kinase inhibitors for the treatment of cancer" (New Jersey, New York, Oregon, California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,688, issued on July 21, was assigned to SCHRODINGER INC. (N.Y.). "Heterocyclic pericondensed CDC7 kinase inhibitors for the treatment of ca... Read More


US Patent Issued to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) on July 21 for "HPK1 inhibitor, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,689, issued on July 21, was assigned to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) Co. LTD. (Shanghai). "HPK1 inhibitor, preparation method th... Read More


US Patent Issued to Merck Sharp & Dohme on July 21 for "Macrocyclic urea orexin receptor agonists" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,690, issued on July 21, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Macrocyclic urea orexin receptor agonists" was invented by... Read More